Autorefractor and Keratometer Market Key Insights, Size, Share, and Forecast Report 2032

The autorefractor and keratometer market comprises diagnostic devices used in eye care, including autorefractors for measuring refractive errors (like myopia and astigmatism) and keratometers for assessing corneal curvature. These instruments enhance eye exams by providing fast, objective, and accurate measurements, making them essential in settings such as hospitals, optometry clinics, and optical retail centers. Market growth is driven by rising rates of vision disorders, technological advances (like AI integration and portable models), and expanding access to eye care in emerging regions. North America leads the market due to advanced healthcare infrastructure and high adoption, while the Asia-Pacific region is emerging as the fastest-growing area. Despite their value, challenges such as high equipment costs and a shortage of trained staff in resource-limited areas continue to limit broader adoption.

According to Fortune Business Insights, the global autorefractor and keratometer market was valued at USD 69.7 million in 2024 and is projected to grow from USD 73.3 million in 2025 to USD 107.1 million by 2032, exhibiting a compound annual growth rate (CAGR) of 5.6% during the forecast period. In 2024, North America dominated the market with a 35% share.

Top Companies in the Market

• EssilorLuxottica (France)

• Carl Zeiss Meditech AG (Germany)

• Topcon Corporation (Japan)

• CANON MEDICAL SYSTEMS CORPORATION (Japan)

• NIDEK CO., LTD. (Japan)

• Bausch + Lomb (Canada)

• Visionix (U.S.)

• Remidio Innovative Solutions Pvt Ltd. (India)

Key Industry Development

In July 2024, EssilorLuxottica acquired an 80.0% stake in Heidelberg Engineering, a company specializing in diagnostic solutions, healthcare IT, and digital surgical technologies for clinical ophthalmology, signaling a strategic expansion in diagnostic and surgical-ready ophthalmic technologies.

Market Drivers & Restraints

Drivers

Rising prevalence of ocular conditions such as hyperopia, astigmatism, myopia, and cataracts—fueled by aging populations, lifestyle changes, and increasing diabetes rates—is driving demand for early diagnosis and boosting market expansion.

Restraints

Adoption in low- and middle-income countries is hindered by limited awareness of eye diagnostics and high cost barriers. High-end autorefractor models can cost upwards of USD 25,000, making them prohibitive for resource-constrained settings.

Market Segments

By Product Type

The market is divided into Autorefractor, Keratometer, and Hybrid segments. The Hybrid segment (autorefraction + keratometry in one device) is expected to lead, owing to its higher diagnostic accuracy. For instance, in April 2024, NIDEK launched the fully automated ARK-F/AR-F auto ref/keratometer.

Autorefractor-only devices are also expected to grow substantially as manufacturers integrate AI and machine learning to enhance diagnostics.

By Portability

The market is segmented into Tabletop and Handheld systems. Tabletop instruments are preferred in optometric offices for comprehensive examinations and are expected to dominate.

Handheld devices are gaining traction due to their portability and convenience, especially for mobile clinics, home visits, and underserved areas. Remidio, for example, launched the Instaref R20 portable autorefractor in October 2022 using Shack-Hartmann aberrometry.

By Indication

The indications include Hyperopia, Myopia, Astigmatism, and Others (e.g., keratoconus, cataracts). In 2024, the Hyperopia segment held the largest share, driven by its prevalence in both adults and children. The Cleveland Clinic estimated that hyperopia affects around 4.6% of children and 30.9% of adults globally.

Myopia is expected to show notable growth, propelled by rising screen time and an aging population. Astigmatism maintains substantial share due to availability of advanced diagnostic devices, and the “Others” category remains steady, with recurrent need for diagnosis of keratoconus, cataracts, etc. 

By End-User

The market is segmented into Hospitals, Ophthalmic Clinics, and Others (e.g., telehealth, academic clinics). In 2024, Hospitals dominated due to large diagnostic volumes and advanced infrastructure.

Ophthalmic Clinics are expected to grow at the fastest CAGR, supported by a rising number of clinics globally. For instance, UC Davis Health launched a new eye care facility in Sacramento in December 2022.

The Others segment, including telehealth and academic clinics, is set to expand significantly amid partnerships aimed at improving diagnostic access.

Explore the full research report with detailed insights and TOC: https://www.fortunebusinessinsights.com/autorefractor-and-keratometer-market-113649 

Market Regional Insights

The market is analyzed across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

• North America: Dominated the market in 2024 with USD 24.4 million, driven by robust healthcare infrastructure, reimbursement policies, and presence of major players. In the U.S., a high burden of diabetes (38.4 million individuals in 2024) has prompted greater ophthalmic diagnostic adoption; in Canada, growing incidence of ocular conditions like keratoconus and astigmatism fuels demand.

• Europe: Holds a substantial share due to stringent medical device regulations and a large population of ophthalmologists.

• Asia Pacific: Expected to grow fastest, backed by investment in ophthalmic diagnostics across India, China, Japan, and a large patient pool.

Future Market Scope

With a projected CAGR of 5.6% (2025–2032) and growth in demand across regions ranging from developed North America and Europe to fast-growing Asia Pacific, the autorefractor and keratometer market demonstrates robust future potential. Key trends include the rise of hybrid and AI-integrated devices, expansion of portable models for underserved areas, and escalating importance of early detection of refractive errors.

Conclusion

The Autorefractor and Keratometer Market is poised for meaningful growth between 2025 and 2032. Supported by rising ophthalmic needs, advanced diagnostics, and strategic moves by major players, the market is evolving—particularly toward higher-accuracy hybrid devices, portable systems, and enhanced adoption across emerging regions. Awareness, accessibility, and affordability remain challenges, but enhanced collaborations and continued innovations present strong opportunities for the future.

About Us:Fortune Business Insights provides expert corporate analysis and accurate data, enabling businesses of all sizes to make timely decisions. We offer customized solutions tailored to each client’s needs, helping them address unique challenges. Our goal is to empower clients with holistic market intelligence and offer granular insights into the market they operate in.

At Fortune Business Insights, we aim to highlight growth opportunities for our clients, offering insights and recommendations that help them navigate technological and market changes. Our consulting services are designed to help companies uncover hidden opportunities and address competitive challenges.

Contact us:

Fortune Business Insights™ Pvt.

Phone: USA: +1 833 909 2966 (Toll-Free),

United Kingdom: +44 808 502 0280 (Toll-Free),

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com